{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:48:37Z","timestamp":1791863317076,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.jns.2008.06.038","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T09:16:40Z","timestamp":1218705400000},"page":"148-150","source":"Crossref","is-referenced-by-count":31,"title":["NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy"],"prefix":"10.1016","volume":"275","author":[{"given":"Cl\u00e1udia S.K.","family":"Kay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana H.","family":"Scola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J.","family":"Lorenzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Jarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter O.","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lineu C.","family":"Werneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.06.038_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/S0004-282X1999000300018","article-title":"Myasthenia gravis: clinical evaluation of 153 patients","volume":"57","author":"Cunha","year":"1999","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jns.2008.06.038_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0004-282X2008000100034","article-title":"Devic's neuromyelitis optica: a critical review","volume":"66","author":"Lana-Peixoto","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jns.2008.06.038_bb0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1191\/1352458503ms964oa","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia","volume":"9","author":"Isbister","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2008.06.038_bb0020","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1212\/01.WNL.0000115168.73299.88","article-title":"Devic disease and thymoma with anti-central nervous system and antithymus antibodies","volume":"62","author":"Antoine","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2006.01392.x","article-title":"Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population","volume":"13","author":"Furukawa","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2008.06.038_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.06.038_bb0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1212\/01.wnl.0000234142.41728.a0","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis","volume":"67","author":"Gotkine","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0040","first-page":"1327","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis","volume":"68","author":"Gotkine","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/13524585070130030201","article-title":"Clinical and laboratorial features of neuromyelitis optica with oligoclonal IgG bands","volume":"13","author":"Nakamura","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2008.06.038_bb0050","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/01.wnl.0000262954.51568.25","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis","volume":"68","author":"Ikeda","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0004-282X2008000100002","article-title":"Demyelinating disease in patients with myasthenia gravis","volume":"66","author":"Bichuetti","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jns.2008.06.038_bb0060","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","article-title":"NMO-IgG in the diagnosis of neuromyelitis optica","volume":"68","author":"Jarius","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0065","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1590\/S0004-282X2004000300032","article-title":"Recurrent neuromyelitis optica with diffuse central nervous system involvement","volume":"62","author":"Domingues","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jns.2008.06.038_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.06.038_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1179\/016164106X115071","article-title":"The spectrum of neuromyelitis optica: a case of NMO with extensive brain stem involvement","volume":"29","author":"Vendrame","year":"2007","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2008.06.038_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0004-282X2008000100001","article-title":"Neuromyelitis optica: brain abnormalities in a Brazilian cohort","volume":"66","author":"Bichuetti","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jns.2008.06.038_bb0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0404.1989.tb03881.x","article-title":"Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy","volume":"80","author":"Thorlacius","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2008.06.038_bb0095","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2008.06.038_bb0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2008.06.038_bb0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.jns.2008.06.038_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.48.1.58","article-title":"Recurrent optic neuromyelitis with endocrinopathies: a new syndrome","volume":"45","author":"Vernant","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.06.038_bb0115","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.06.038_bb0120","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4049\/jimmunol.177.3.1500","article-title":"The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis","volume":"177","author":"Song","year":"2006","journal-title":"J Immunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:16:34Z","timestamp":1557742594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0022510X08003225"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.06.038","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}